mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.4 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.4 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.4 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.047 |
0.4 |